nodes	percent_of_prediction	percent_of_DWPC	metapath
Nifedipine—CYP1A1—Riluzole—amyotrophic lateral sclerosis	0.391	0.691	CbGbCtD
Nifedipine—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.175	0.309	CbGbCtD
Nifedipine—Stridor—Riluzole—amyotrophic lateral sclerosis	0.00727	0.0317	CcSEcCtD
Nifedipine—Gastrointestinal tract irritation—Riluzole—amyotrophic lateral sclerosis	0.00664	0.0289	CcSEcCtD
Nifedipine—KCNA1—nerve—amyotrophic lateral sclerosis	0.00534	0.0614	CbGeAlD
Nifedipine—CALM1—cranial nerve—amyotrophic lateral sclerosis	0.00421	0.0484	CbGeAlD
Nifedipine—Gingival bleeding—Riluzole—amyotrophic lateral sclerosis	0.00418	0.0182	CcSEcCtD
Nifedipine—CALM2—pons—amyotrophic lateral sclerosis	0.00418	0.048	CbGeAlD
Nifedipine—CALM1—pons—amyotrophic lateral sclerosis	0.00416	0.0478	CbGeAlD
Nifedipine—KCNA1—hindbrain—amyotrophic lateral sclerosis	0.004	0.046	CbGeAlD
Nifedipine—Enlargement abdomen—Riluzole—amyotrophic lateral sclerosis	0.00394	0.0172	CcSEcCtD
Nifedipine—Myasthenia—Riluzole—amyotrophic lateral sclerosis	0.00377	0.0164	CcSEcCtD
Nifedipine—Calculus of kidney—Riluzole—amyotrophic lateral sclerosis	0.00362	0.0158	CcSEcCtD
Nifedipine—Intestinal obstruction—Riluzole—amyotrophic lateral sclerosis	0.00348	0.0152	CcSEcCtD
Nifedipine—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.00307	0.0134	CcSEcCtD
Nifedipine—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.00295	0.0129	CcSEcCtD
Nifedipine—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.00295	0.0129	CcSEcCtD
Nifedipine—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.00288	0.0126	CcSEcCtD
Nifedipine—Gamma-glutamyltransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00288	0.0126	CcSEcCtD
Nifedipine—CACNA2D1—hindbrain—amyotrophic lateral sclerosis	0.00287	0.033	CbGeAlD
Nifedipine—CALM2—peripheral nervous system—amyotrophic lateral sclerosis	0.00278	0.0319	CbGeAlD
Nifedipine—CALM1—peripheral nervous system—amyotrophic lateral sclerosis	0.00277	0.0318	CbGeAlD
Nifedipine—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.00272	0.0118	CcSEcCtD
Nifedipine—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.00261	0.0114	CcSEcCtD
Nifedipine—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00261	0.0114	CcSEcCtD
Nifedipine—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.00259	0.0113	CcSEcCtD
Nifedipine—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.00255	0.0111	CcSEcCtD
Nifedipine—Gout—Riluzole—amyotrophic lateral sclerosis	0.00254	0.0111	CcSEcCtD
Nifedipine—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.00251	0.0109	CcSEcCtD
Nifedipine—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.0024	0.0105	CcSEcCtD
Nifedipine—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00231	0.0101	CcSEcCtD
Nifedipine—KCNA1—brainstem—amyotrophic lateral sclerosis	0.00229	0.0264	CbGeAlD
Nifedipine—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00229	0.00998	CcSEcCtD
Nifedipine—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00218	0.00949	CcSEcCtD
Nifedipine—CALM2—nerve—amyotrophic lateral sclerosis	0.00217	0.0249	CbGeAlD
Nifedipine—Coma—Riluzole—amyotrophic lateral sclerosis	0.00217	0.00944	CcSEcCtD
Nifedipine—CALM1—nerve—amyotrophic lateral sclerosis	0.00216	0.0248	CbGeAlD
Nifedipine—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.00211	0.0092	CcSEcCtD
Nifedipine—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00906	CcSEcCtD
Nifedipine—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00206	0.00897	CcSEcCtD
Nifedipine—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00879	CcSEcCtD
Nifedipine—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.002	0.00871	CcSEcCtD
Nifedipine—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00192	0.00839	CcSEcCtD
Nifedipine—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.0019	0.00827	CcSEcCtD
Nifedipine—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00186	0.00809	CcSEcCtD
Nifedipine—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00183	0.00798	CcSEcCtD
Nifedipine—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00182	0.00795	CcSEcCtD
Nifedipine—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00182	0.00792	CcSEcCtD
Nifedipine—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00181	0.00788	CcSEcCtD
Nifedipine—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00778	CcSEcCtD
Nifedipine—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00775	CcSEcCtD
Nifedipine—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00772	CcSEcCtD
Nifedipine—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00769	CcSEcCtD
Nifedipine—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00172	0.0075	CcSEcCtD
Nifedipine—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00172	0.0075	CcSEcCtD
Nifedipine—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00172	0.0075	CcSEcCtD
Nifedipine—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00744	CcSEcCtD
Nifedipine—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00169	0.00738	CcSEcCtD
Nifedipine—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00169	0.00738	CcSEcCtD
Nifedipine—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00724	CcSEcCtD
Nifedipine—CACNA2D1—brainstem—amyotrophic lateral sclerosis	0.00165	0.0189	CbGeAlD
Nifedipine—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00164	0.00713	CcSEcCtD
Nifedipine—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00711	CcSEcCtD
Nifedipine—CALM2—hindbrain—amyotrophic lateral sclerosis	0.00162	0.0187	CbGeAlD
Nifedipine—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00705	CcSEcCtD
Nifedipine—CALM1—hindbrain—amyotrophic lateral sclerosis	0.00161	0.0186	CbGeAlD
Nifedipine—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00159	0.00693	CcSEcCtD
Nifedipine—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00685	CcSEcCtD
Nifedipine—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00678	CcSEcCtD
Nifedipine—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00662	CcSEcCtD
Nifedipine—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00662	CcSEcCtD
Nifedipine—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00653	CcSEcCtD
Nifedipine—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00149	0.00648	CcSEcCtD
Nifedipine—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00632	CcSEcCtD
Nifedipine—KCNA1—spinal cord—amyotrophic lateral sclerosis	0.00143	0.0164	CbGeAlD
Nifedipine—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00622	CcSEcCtD
Nifedipine—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00606	CcSEcCtD
Nifedipine—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00599	CcSEcCtD
Nifedipine—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00597	CcSEcCtD
Nifedipine—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00592	CcSEcCtD
Nifedipine—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00135	0.0059	CcSEcCtD
Nifedipine—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00587	CcSEcCtD
Nifedipine—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00563	CcSEcCtD
Nifedipine—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00554	CcSEcCtD
Nifedipine—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00551	CcSEcCtD
Nifedipine—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00125	0.00547	CcSEcCtD
Nifedipine—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00125	0.00545	CcSEcCtD
Nifedipine—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00542	CcSEcCtD
Nifedipine—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00539	CcSEcCtD
Nifedipine—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00528	CcSEcCtD
Nifedipine—KCNA1—nervous system—amyotrophic lateral sclerosis	0.0012	0.0138	CbGeAlD
Nifedipine—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00522	CcSEcCtD
Nifedipine—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00119	0.0052	CcSEcCtD
Nifedipine—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00519	CcSEcCtD
Nifedipine—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00519	CcSEcCtD
Nifedipine—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00516	CcSEcCtD
Nifedipine—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00515	CcSEcCtD
Nifedipine—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00513	CcSEcCtD
Nifedipine—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00511	CcSEcCtD
Nifedipine—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00117	0.0051	CcSEcCtD
Nifedipine—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00509	CcSEcCtD
Nifedipine—KCNA1—central nervous system—amyotrophic lateral sclerosis	0.00116	0.0133	CbGeAlD
Nifedipine—KCNA1—cerebellum—amyotrophic lateral sclerosis	0.00113	0.013	CbGeAlD
Nifedipine—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00491	CcSEcCtD
Nifedipine—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00485	CcSEcCtD
Nifedipine—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00482	CcSEcCtD
Nifedipine—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00471	CcSEcCtD
Nifedipine—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00469	CcSEcCtD
Nifedipine—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00468	CcSEcCtD
Nifedipine—Chills—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00466	CcSEcCtD
Nifedipine—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00464	CcSEcCtD
Nifedipine—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00459	CcSEcCtD
Nifedipine—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00455	CcSEcCtD
Nifedipine—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00452	CcSEcCtD
Nifedipine—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00445	CcSEcCtD
Nifedipine—Tension—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00443	CcSEcCtD
Nifedipine—CALM2—embryo—amyotrophic lateral sclerosis	0.00101	0.0117	CbGeAlD
Nifedipine—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00442	CcSEcCtD
Nifedipine—CALM1—embryo—amyotrophic lateral sclerosis	0.00101	0.0116	CbGeAlD
Nifedipine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00439	CcSEcCtD
Nifedipine—Back pain—Riluzole—amyotrophic lateral sclerosis	0.001	0.00437	CcSEcCtD
Nifedipine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.000996	0.00434	CcSEcCtD
Nifedipine—CACNA1H—nervous system—amyotrophic lateral sclerosis	0.000972	0.0112	CbGeAlD
Nifedipine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000971	0.00423	CcSEcCtD
Nifedipine—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000961	0.00419	CcSEcCtD
Nifedipine—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000958	0.00418	CcSEcCtD
Nifedipine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000952	0.00415	CcSEcCtD
Nifedipine—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.000947	0.00413	CcSEcCtD
Nifedipine—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000934	0.00407	CcSEcCtD
Nifedipine—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000931	0.00406	CcSEcCtD
Nifedipine—CALM2—brainstem—amyotrophic lateral sclerosis	0.00093	0.0107	CbGeAlD
Nifedipine—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000929	0.00405	CcSEcCtD
Nifedipine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000927	0.00404	CcSEcCtD
Nifedipine—CALM1—brainstem—amyotrophic lateral sclerosis	0.000926	0.0106	CbGeAlD
Nifedipine—KCNA1—brain—amyotrophic lateral sclerosis	0.000918	0.0106	CbGeAlD
Nifedipine—CACNB2—nervous system—amyotrophic lateral sclerosis	0.000918	0.0106	CbGeAlD
Nifedipine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.000916	0.00399	CcSEcCtD
Nifedipine—CACNA1H—cerebellum—amyotrophic lateral sclerosis	0.000915	0.0105	CbGeAlD
Nifedipine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000911	0.00397	CcSEcCtD
Nifedipine—Cough—Riluzole—amyotrophic lateral sclerosis	0.000904	0.00394	CcSEcCtD
Nifedipine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.000896	0.0103	CbGeAlD
Nifedipine—CACNB2—central nervous system—amyotrophic lateral sclerosis	0.000884	0.0102	CbGeAlD
Nifedipine—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000882	0.00385	CcSEcCtD
Nifedipine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000882	0.00385	CcSEcCtD
Nifedipine—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000882	0.00385	CcSEcCtD
Nifedipine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000879	0.00383	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.000876	0.00382	CcSEcCtD
Nifedipine—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000871	0.0038	CcSEcCtD
Nifedipine—CACNB2—cerebellum—amyotrophic lateral sclerosis	0.000864	0.00993	CbGeAlD
Nifedipine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000863	0.00376	CcSEcCtD
Nifedipine—CACNA2D1—nervous system—amyotrophic lateral sclerosis	0.000862	0.00991	CbGeAlD
Nifedipine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000853	0.00372	CcSEcCtD
Nifedipine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000846	0.00369	CcSEcCtD
Nifedipine—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.000846	0.00369	CcSEcCtD
Nifedipine—Shock—Riluzole—amyotrophic lateral sclerosis	0.000832	0.00363	CcSEcCtD
Nifedipine—CACNA2D1—central nervous system—amyotrophic lateral sclerosis	0.00083	0.00954	CbGeAlD
Nifedipine—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000829	0.00362	CcSEcCtD
Nifedipine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000828	0.00361	CcSEcCtD
Nifedipine—CALM3—medulla oblongata—amyotrophic lateral sclerosis	0.000826	0.00949	CbGeAlD
Nifedipine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000825	0.0036	CcSEcCtD
Nifedipine—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000821	0.00358	CcSEcCtD
Nifedipine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000817	0.00356	CcSEcCtD
Nifedipine—CACNA2D1—cerebellum—amyotrophic lateral sclerosis	0.000811	0.00933	CbGeAlD
Nifedipine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000806	0.00351	CcSEcCtD
Nifedipine—CACNA1D—nervous system—amyotrophic lateral sclerosis	0.000802	0.00922	CbGeAlD
Nifedipine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00079	0.00345	CcSEcCtD
Nifedipine—CACNA1D—central nervous system—amyotrophic lateral sclerosis	0.000772	0.00888	CbGeAlD
Nifedipine—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00077	0.00336	CcSEcCtD
Nifedipine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000765	0.00333	CcSEcCtD
Nifedipine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000759	0.00331	CcSEcCtD
Nifedipine—CACNA1D—cerebellum—amyotrophic lateral sclerosis	0.000755	0.00868	CbGeAlD
Nifedipine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000754	0.00329	CcSEcCtD
Nifedipine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000752	0.00328	CcSEcCtD
Nifedipine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000744	0.00325	CcSEcCtD
Nifedipine—CACNA1H—brain—amyotrophic lateral sclerosis	0.000743	0.00854	CbGeAlD
Nifedipine—CACNA1C—nervous system—amyotrophic lateral sclerosis	0.000741	0.00852	CbGeAlD
Nifedipine—CALM3—spinal cord—amyotrophic lateral sclerosis	0.000736	0.00846	CbGeAlD
Nifedipine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000735	0.00321	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00073	0.00318	CcSEcCtD
Nifedipine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000729	0.00318	CcSEcCtD
Nifedipine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000723	0.00315	CcSEcCtD
Nifedipine—Pain—Riluzole—amyotrophic lateral sclerosis	0.000723	0.00315	CcSEcCtD
Nifedipine—CACNA1C—central nervous system—amyotrophic lateral sclerosis	0.000713	0.0082	CbGeAlD
Nifedipine—CACNB2—brain—amyotrophic lateral sclerosis	0.000702	0.00807	CbGeAlD
Nifedipine—CACNA1C—cerebellum—amyotrophic lateral sclerosis	0.000697	0.00801	CbGeAlD
Nifedipine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000697	0.00304	CcSEcCtD
Nifedipine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000691	0.00301	CcSEcCtD
Nifedipine—CYP2A6—cerebellum—amyotrophic lateral sclerosis	0.000677	0.00778	CbGeAlD
Nifedipine—ABCC3—nervous system—amyotrophic lateral sclerosis	0.000674	0.00775	CbGeAlD
Nifedipine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000672	0.00293	CcSEcCtD
Nifedipine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000668	0.00291	CcSEcCtD
Nifedipine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000668	0.00291	CcSEcCtD
Nifedipine—CACNA2D1—brain—amyotrophic lateral sclerosis	0.000659	0.00758	CbGeAlD
Nifedipine—ABCC3—central nervous system—amyotrophic lateral sclerosis	0.000649	0.00746	CbGeAlD
Nifedipine—CALM2—medulla oblongata—amyotrophic lateral sclerosis	0.000648	0.00745	CbGeAlD
Nifedipine—CALM1—medulla oblongata—amyotrophic lateral sclerosis	0.000645	0.00742	CbGeAlD
Nifedipine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000623	0.00272	CcSEcCtD
Nifedipine—CACNA1D—brain—amyotrophic lateral sclerosis	0.000613	0.00705	CbGeAlD
Nifedipine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000607	0.00265	CcSEcCtD
Nifedipine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000598	0.00261	CcSEcCtD
Nifedipine—CALM3—cerebellum—amyotrophic lateral sclerosis	0.000584	0.00671	CbGeAlD
Nifedipine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000579	0.00252	CcSEcCtD
Nifedipine—CALM2—spinal cord—amyotrophic lateral sclerosis	0.000578	0.00665	CbGeAlD
Nifedipine—CALM1—spinal cord—amyotrophic lateral sclerosis	0.000575	0.00662	CbGeAlD
Nifedipine—CACNA1C—brain—amyotrophic lateral sclerosis	0.000566	0.00651	CbGeAlD
Nifedipine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000559	0.00244	CcSEcCtD
Nifedipine—CYP2A6—brain—amyotrophic lateral sclerosis	0.00055	0.00632	CbGeAlD
Nifedipine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000538	0.00234	CcSEcCtD
Nifedipine—Rash—Riluzole—amyotrophic lateral sclerosis	0.000533	0.00232	CcSEcCtD
Nifedipine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000533	0.00232	CcSEcCtD
Nifedipine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00053	0.00231	CcSEcCtD
Nifedipine—ABCC3—brain—amyotrophic lateral sclerosis	0.000515	0.00592	CbGeAlD
Nifedipine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.000514	0.00591	CbGeAlD
Nifedipine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000502	0.00219	CcSEcCtD
Nifedipine—CALM2—nervous system—amyotrophic lateral sclerosis	0.000487	0.0056	CbGeAlD
Nifedipine—CALM1—nervous system—amyotrophic lateral sclerosis	0.000485	0.00558	CbGeAlD
Nifedipine—CALM3—brain—amyotrophic lateral sclerosis	0.000474	0.00545	CbGeAlD
Nifedipine—CALM2—central nervous system—amyotrophic lateral sclerosis	0.000469	0.00539	CbGeAlD
Nifedipine—CALM1—central nervous system—amyotrophic lateral sclerosis	0.000467	0.00537	CbGeAlD
Nifedipine—CALM2—cerebellum—amyotrophic lateral sclerosis	0.000458	0.00527	CbGeAlD
Nifedipine—CALM1—cerebellum—amyotrophic lateral sclerosis	0.000456	0.00525	CbGeAlD
Nifedipine—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.000452	0.0052	CbGeAlD
Nifedipine—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.000403	0.00464	CbGeAlD
Nifedipine—ABCB1—embryo—amyotrophic lateral sclerosis	0.000403	0.00464	CbGeAlD
Nifedipine—CYP1A1—nervous system—amyotrophic lateral sclerosis	0.000373	0.00428	CbGeAlD
Nifedipine—CALM2—brain—amyotrophic lateral sclerosis	0.000372	0.00428	CbGeAlD
Nifedipine—CALM1—brain—amyotrophic lateral sclerosis	0.000371	0.00426	CbGeAlD
Nifedipine—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.000362	0.00416	CbGeAlD
Nifedipine—CYP1A1—central nervous system—amyotrophic lateral sclerosis	0.000359	0.00413	CbGeAlD
Nifedipine—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.000349	0.00401	CbGeAlD
Nifedipine—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.00034	0.00391	CbGeAlD
Nifedipine—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.000327	0.00376	CbGeAlD
Nifedipine—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.00032	0.00368	CbGeAlD
Nifedipine—CYP2C8—brain—amyotrophic lateral sclerosis	0.000309	0.00355	CbGeAlD
Nifedipine—CYP1A1—brain—amyotrophic lateral sclerosis	0.000285	0.00328	CbGeAlD
Nifedipine—CYP2B6—brain—amyotrophic lateral sclerosis	0.000277	0.00318	CbGeAlD
Nifedipine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000273	0.00314	CbGeAlD
Nifedipine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000269	0.00309	CbGeAlD
Nifedipine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000263	0.00303	CbGeAlD
Nifedipine—CYP2E1—brain—amyotrophic lateral sclerosis	0.00026	0.00299	CbGeAlD
Nifedipine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000259	0.00298	CbGeAlD
Nifedipine—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000258	0.00296	CbGeAlD
Nifedipine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000253	0.00291	CbGeAlD
Nifedipine—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.00023	0.00264	CbGeAlD
Nifedipine—CYP2D6—brain—amyotrophic lateral sclerosis	0.000206	0.00236	CbGeAlD
Nifedipine—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000194	0.00223	CbGeAlD
Nifedipine—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000186	0.00214	CbGeAlD
Nifedipine—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000182	0.00209	CbGeAlD
Nifedipine—ABCB1—brain—amyotrophic lateral sclerosis	0.000148	0.0017	CbGeAlD
Nifedipine—CALM3—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	2.77e-05	0.000235	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—GSR—amyotrophic lateral sclerosis	2.76e-05	0.000235	CbGpPWpGaD
Nifedipine—CALM2—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	2.68e-05	0.000228	CbGpPWpGaD
Nifedipine—CALM1—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	2.68e-05	0.000228	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—GSR—amyotrophic lateral sclerosis	2.67e-05	0.000227	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—GSR—amyotrophic lateral sclerosis	2.67e-05	0.000227	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	2.65e-05	0.000225	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	2.64e-05	0.000225	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—GSR—amyotrophic lateral sclerosis	2.62e-05	0.000223	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	2.61e-05	0.000222	CbGpPWpGaD
Nifedipine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	2.58e-05	0.000219	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	2.56e-05	0.000218	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	2.56e-05	0.000218	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	2.55e-05	0.000217	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	2.55e-05	0.000217	CbGpPWpGaD
Nifedipine—CACNA1C—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.54e-05	0.000216	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—ERBB4—amyotrophic lateral sclerosis	2.54e-05	0.000216	CbGpPWpGaD
Nifedipine—CACNB2—Metabolism—APOE—amyotrophic lateral sclerosis	2.52e-05	0.000214	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	2.5e-05	0.000213	CbGpPWpGaD
Nifedipine—ABCC3—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.48e-05	0.000211	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—ERBB4—amyotrophic lateral sclerosis	2.46e-05	0.000209	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—ERBB4—amyotrophic lateral sclerosis	2.46e-05	0.000209	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	2.42e-05	0.000206	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	2.42e-05	0.000206	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	2.4e-05	0.000205	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	2.39e-05	0.000203	CbGpPWpGaD
Nifedipine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	2.39e-05	0.000203	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—CD40LG—amyotrophic lateral sclerosis	2.39e-05	0.000203	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.39e-05	0.000203	CbGpPWpGaD
Nifedipine—CALM3—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	2.38e-05	0.000203	CbGpPWpGaD
Nifedipine—CACNA1D—Metabolism—APOE—amyotrophic lateral sclerosis	2.38e-05	0.000203	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	2.36e-05	0.0002	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	2.33e-05	0.000199	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	2.33e-05	0.000198	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—CD40LG—amyotrophic lateral sclerosis	2.31e-05	0.000197	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—CD40LG—amyotrophic lateral sclerosis	2.31e-05	0.000197	CbGpPWpGaD
Nifedipine—CALM2—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	2.3e-05	0.000196	CbGpPWpGaD
Nifedipine—CALM1—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	2.3e-05	0.000196	CbGpPWpGaD
Nifedipine—CALM3—Disease—CST3—amyotrophic lateral sclerosis	2.29e-05	0.000195	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.28e-05	0.000194	CbGpPWpGaD
Nifedipine—CALM3—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	2.28e-05	0.000194	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	2.28e-05	0.000194	CbGpPWpGaD
Nifedipine—ABCC3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.28e-05	0.000194	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	2.28e-05	0.000194	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	2.28e-05	0.000194	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.27e-05	0.000193	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—CHAT—amyotrophic lateral sclerosis	2.27e-05	0.000193	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—VCP—amyotrophic lateral sclerosis	2.23e-05	0.00019	CbGpPWpGaD
Nifedipine—CALM1—Disease—CST3—amyotrophic lateral sclerosis	2.21e-05	0.000188	CbGpPWpGaD
Nifedipine—CALM2—Disease—CST3—amyotrophic lateral sclerosis	2.21e-05	0.000188	CbGpPWpGaD
Nifedipine—CALM2—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	2.21e-05	0.000188	CbGpPWpGaD
Nifedipine—CALM1—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	2.21e-05	0.000188	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—C3—amyotrophic lateral sclerosis	2.2e-05	0.000187	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—CHAT—amyotrophic lateral sclerosis	2.2e-05	0.000187	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.2e-05	0.000187	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.19e-05	0.000186	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.17e-05	0.000185	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	2.16e-05	0.000184	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	2.16e-05	0.000184	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	2.16e-05	0.000184	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.15e-05	0.000183	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	2.14e-05	0.000182	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—C3—amyotrophic lateral sclerosis	2.13e-05	0.000181	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—C3—amyotrophic lateral sclerosis	2.13e-05	0.000181	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	2.12e-05	0.00018	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—C3—amyotrophic lateral sclerosis	2.11e-05	0.00018	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	2.1e-05	0.000178	CbGpPWpGaD
Nifedipine—CACNA1C—Metabolism—APOE—amyotrophic lateral sclerosis	2.09e-05	0.000178	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	2.09e-05	0.000178	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	2.09e-05	0.000178	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—C3—amyotrophic lateral sclerosis	2.04e-05	0.000174	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—C3—amyotrophic lateral sclerosis	2.04e-05	0.000174	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	2.04e-05	0.000174	CbGpPWpGaD
Nifedipine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	2.03e-05	0.000173	CbGpPWpGaD
Nifedipine—CALM3—Immune System—SQSTM1—amyotrophic lateral sclerosis	2.02e-05	0.000172	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	1.97e-05	0.000168	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	1.97e-05	0.000168	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.97e-05	0.000167	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	1.96e-05	0.000166	CbGpPWpGaD
Nifedipine—CALM1—Immune System—SQSTM1—amyotrophic lateral sclerosis	1.95e-05	0.000166	CbGpPWpGaD
Nifedipine—CALM2—Immune System—SQSTM1—amyotrophic lateral sclerosis	1.95e-05	0.000166	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.92e-05	0.000163	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.9e-05	0.000161	CbGpPWpGaD
Nifedipine—CALM3—Immune System—ATF1—amyotrophic lateral sclerosis	1.89e-05	0.000161	CbGpPWpGaD
Nifedipine—CALM3—Hemostasis—IGF1—amyotrophic lateral sclerosis	1.88e-05	0.00016	CbGpPWpGaD
Nifedipine—ABCC3—Metabolism—APOE—amyotrophic lateral sclerosis	1.88e-05	0.000159	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.86e-05	0.000158	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.86e-05	0.000158	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	1.85e-05	0.000157	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.84e-05	0.000156	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.84e-05	0.000156	CbGpPWpGaD
Nifedipine—CALM1—Immune System—ATF1—amyotrophic lateral sclerosis	1.83e-05	0.000156	CbGpPWpGaD
Nifedipine—CALM2—Immune System—ATF1—amyotrophic lateral sclerosis	1.83e-05	0.000156	CbGpPWpGaD
Nifedipine—CALM1—Hemostasis—IGF1—amyotrophic lateral sclerosis	1.82e-05	0.000155	CbGpPWpGaD
Nifedipine—CALM2—Hemostasis—IGF1—amyotrophic lateral sclerosis	1.82e-05	0.000155	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.81e-05	0.000154	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.8e-05	0.000153	CbGpPWpGaD
Nifedipine—CALM3—Immune System—CASP9—amyotrophic lateral sclerosis	1.8e-05	0.000153	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.78e-05	0.000152	CbGpPWpGaD
Nifedipine—CALM2—Immune System—CASP9—amyotrophic lateral sclerosis	1.74e-05	0.000148	CbGpPWpGaD
Nifedipine—CALM1—Immune System—CASP9—amyotrophic lateral sclerosis	1.74e-05	0.000148	CbGpPWpGaD
Nifedipine—CACNB2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.72e-05	0.000147	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.72e-05	0.000146	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.7e-05	0.000144	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	1.67e-05	0.000142	CbGpPWpGaD
Nifedipine—CALM3—Disease—CASP9—amyotrophic lateral sclerosis	1.66e-05	0.000141	CbGpPWpGaD
Nifedipine—CACNA1D—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.63e-05	0.000139	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.62e-05	0.000138	CbGpPWpGaD
Nifedipine—CALM2—Disease—CASP9—amyotrophic lateral sclerosis	1.61e-05	0.000137	CbGpPWpGaD
Nifedipine—CALM1—Disease—CASP9—amyotrophic lateral sclerosis	1.61e-05	0.000137	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	1.61e-05	0.000137	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.59e-05	0.000135	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.56e-05	0.000132	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.55e-05	0.000132	CbGpPWpGaD
Nifedipine—CALM3—Immune System—ERBB4—amyotrophic lateral sclerosis	1.54e-05	0.000131	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.54e-05	0.000131	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.54e-05	0.000131	CbGpPWpGaD
Nifedipine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.53e-05	0.00013	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.52e-05	0.00013	CbGpPWpGaD
Nifedipine—CALM1—Immune System—ERBB4—amyotrophic lateral sclerosis	1.49e-05	0.000127	CbGpPWpGaD
Nifedipine—CALM2—Immune System—ERBB4—amyotrophic lateral sclerosis	1.49e-05	0.000127	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.47e-05	0.000125	CbGpPWpGaD
Nifedipine—CALM3—Immune System—CD40LG—amyotrophic lateral sclerosis	1.45e-05	0.000123	CbGpPWpGaD
Nifedipine—CACNA1C—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.43e-05	0.000122	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.43e-05	0.000121	CbGpPWpGaD
Nifedipine—CALM3—Disease—ERBB4—amyotrophic lateral sclerosis	1.42e-05	0.000121	CbGpPWpGaD
Nifedipine—CALM2—Immune System—CD40LG—amyotrophic lateral sclerosis	1.4e-05	0.000119	CbGpPWpGaD
Nifedipine—CALM1—Immune System—CD40LG—amyotrophic lateral sclerosis	1.4e-05	0.000119	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.4e-05	0.000119	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	1.4e-05	0.000119	CbGpPWpGaD
Nifedipine—CALM1—Disease—ERBB4—amyotrophic lateral sclerosis	1.38e-05	0.000117	CbGpPWpGaD
Nifedipine—CALM2—Disease—ERBB4—amyotrophic lateral sclerosis	1.38e-05	0.000117	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.37e-05	0.000117	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.36e-05	0.000115	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.36e-05	0.000115	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.35e-05	0.000115	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.3e-05	0.000111	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	1.29e-05	0.00011	CbGpPWpGaD
Nifedipine—ABCC3—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.29e-05	0.000109	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—APOE—amyotrophic lateral sclerosis	1.28e-05	0.000109	CbGpPWpGaD
Nifedipine—CALM3—Immune System—C3—amyotrophic lateral sclerosis	1.28e-05	0.000109	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.26e-05	0.000107	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.26e-05	0.000107	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.25e-05	0.000107	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.25e-05	0.000107	CbGpPWpGaD
Nifedipine—CALM2—Immune System—C3—amyotrophic lateral sclerosis	1.24e-05	0.000105	CbGpPWpGaD
Nifedipine—CALM1—Immune System—C3—amyotrophic lateral sclerosis	1.24e-05	0.000105	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.23e-05	0.000105	CbGpPWpGaD
Nifedipine—CALM3—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.23e-05	0.000104	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.23e-05	0.000104	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.23e-05	0.000104	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.22e-05	0.000104	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.22e-05	0.000104	CbGpPWpGaD
Nifedipine—CALM1—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.19e-05	0.000101	CbGpPWpGaD
Nifedipine—CALM2—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.19e-05	0.000101	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.18e-05	0.000101	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.18e-05	0.000101	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.18e-05	0.0001	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.18e-05	0.0001	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—APOE—amyotrophic lateral sclerosis	1.17e-05	9.99e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.17e-05	9.91e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.16e-05	9.85e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.15e-05	9.8e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.13e-05	9.6e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.13e-05	9.58e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.13e-05	9.58e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.13e-05	9.58e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.12e-05	9.54e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—APOE—amyotrophic lateral sclerosis	1.1e-05	9.37e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.08e-05	9.22e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.08e-05	9.22e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—APOE—amyotrophic lateral sclerosis	1.07e-05	9.06e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—APOE—amyotrophic lateral sclerosis	1.07e-05	9.06e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.06e-05	9.05e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.06e-05	9.03e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	1.06e-05	9.01e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1e-05	8.55e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.97e-06	8.48e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.75e-06	8.29e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.65e-06	8.2e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.65e-06	8.2e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	9.48e-06	8.06e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.38e-06	7.97e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	9.28e-06	7.9e-05	CbGpPWpGaD
Nifedipine—CALM3—Hemostasis—TP53—amyotrophic lateral sclerosis	9.28e-06	7.89e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	9.27e-06	7.88e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.25e-06	7.86e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—APOE—amyotrophic lateral sclerosis	9.23e-06	7.85e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.07e-06	7.71e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.07e-06	7.71e-05	CbGpPWpGaD
Nifedipine—CALM1—Hemostasis—TP53—amyotrophic lateral sclerosis	8.98e-06	7.63e-05	CbGpPWpGaD
Nifedipine—CALM2—Hemostasis—TP53—amyotrophic lateral sclerosis	8.98e-06	7.63e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—APOE—amyotrophic lateral sclerosis	8.92e-06	7.59e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—APOE—amyotrophic lateral sclerosis	8.92e-06	7.59e-05	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.78e-06	7.47e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—APOE—amyotrophic lateral sclerosis	8.75e-06	7.44e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.71e-06	7.41e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.64e-06	7.35e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	8.59e-06	7.3e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.5e-06	7.23e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.29e-06	7.05e-05	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.05e-06	6.85e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	8.03e-06	6.82e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.02e-06	6.82e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.02e-06	6.82e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.01e-06	6.81e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.94e-06	6.75e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.71e-06	6.56e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—PTGS2—amyotrophic lateral sclerosis	7.55e-06	6.42e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.46e-06	6.35e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.46e-06	6.35e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.38e-06	6.28e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—PTGS2—amyotrophic lateral sclerosis	7.3e-06	6.21e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—PTGS2—amyotrophic lateral sclerosis	7.3e-06	6.21e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	6.99e-06	5.95e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.78e-06	5.77e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	6.59e-06	5.6e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	6.53e-06	5.55e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.5e-06	5.52e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.37e-06	5.42e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.36e-06	5.41e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.35e-06	5.4e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.32e-06	5.38e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.17e-06	5.24e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.17e-06	5.24e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.11e-06	5.2e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.11e-06	5.2e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	6e-06	5.1e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.7e-06	4.84e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	5.58e-06	4.75e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.5e-06	4.68e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.24e-06	4.45e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.91e-06	4.17e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.79e-06	4.07e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.75e-06	4.04e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.75e-06	4.04e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.64e-06	3.94e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.51e-06	3.84e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.49e-06	3.81e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.49e-06	3.81e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.48e-06	3.81e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	4.31e-06	3.66e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.16e-06	3.54e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.03e-06	3.43e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.03e-06	3.43e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.82e-06	3.25e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.15e-06	2.68e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.04e-06	2.59e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.04e-06	2.59e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.95e-06	2.51e-05	CbGpPWpGaD
